Phase III results of Radiation Therapy Oncology Group (RTOG) 0537 indicate that acupuncture-like, transcutaneous electrical nerve stimulation (ALTENS) may be equally effective as pilocarpine to treat radiation-induced xerostomia (dry mouth). Study results were published in the June 1, 2015 issue of the International Journal of Radiation Oncology • Biology • Physics (Red Journal), the official scientific journal of the American Society for Radiation Oncology (ASTRO). RTOG 0537 is a phase II/III, multi-center, randomized trial comparing ALTENS with pilocarpine, which is the current standard of treatment for radiation-induced xerostomia.

With the introduction of Elekta's new Leksell Gamma Knife Icon, the benefits of precision cranial radiosurgery are now available for more patients with a wider variety of tumor types and sizes. This latest generation stereotactic radiosurgery system for the brain integrates advanced motion management, dose delivery and imaging technologies, significantly increasing the versatility of Gamma Knife radiosurgery. Elekta unveiled Leksell Gamma Knife Icon at the 3^rd European Society for Therapeutic Radiology and Oncology (ESTRO) Forum in Barcelona.

At the American Association of Neurological Surgeons (AANS) annual meeting, May 2-6 in Washington, D.C., Elekta highlighted Leksell Gamma Knife Registry. The cloud-based solution enables clinicians to leverage the data generated by thousands of Gamma Knife radiosurgery treatments each year to advance clinical research and further optimize patient care.

Oxford Instruments plc has acquired Medical Imaging Resources Inc. (MIR). MIR specializes in the build, lease and service of mobile medical imaging labs.

Sectra’s interactive visualization table has been awarded the Dirk Bartz Prize for Visual Computing in Medicine 2015. The prize is awarded by the Eurographics Association, which organizes a biennial competition to acknowledge the contribution that computer graphics is playing in the medical field.